Which has better valuation and earnings, OMDA or CELC?

Omada Health has higher revenue and earnings than Celcuity. Omada Health is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Omada Health $260.21M 5.38 -$12.78M -$0.27 N/A Celcuity N/A N/A -$177.04M -$3.90 N/A

Is OMDA or CELC more profitable?

Celcuity has a net margin of 0.00% compared to Omada Health's net margin of -2.22%. Omada Health's return on equity of -1.82% beat Celcuity's return on equity. Company Net Margins Return on Equity Return on Assets Omada Health -2.22% -1.82% -1.36% Celcuity N/A -244.61% -50.22%

Does the media refer more to OMDA or CELC?

In the previous week, Celcuity had 1 more articles in the media than Omada Health. MarketBeat recorded 12 mentions for Celcuity and 11 mentions for Omada Health. Celcuity's average media sentiment score of 0.82 beat Omada Health's score of 0.75 indicating that Celcuity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Omada Health 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Celcuity 5 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media prefer OMDA or CAI?

In the previous week, Omada Health and Omada Health both had 11 articles in the media. Caris Life Sciences' average media sentiment score of 0.98 beat Omada Health's score of 0.75 indicating that Caris Life Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Omada Health 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Caris Life Sciences 3 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, OMDA or SHC?

Sotera Health has higher revenue and earnings than Omada Health. Omada Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Omada Health $260.21M 5.38 -$12.78M -$0.27 N/A Sotera Health $1.16B 4.43 $77.94M $0.41 44.11

Does the media prefer OMDA or SHC?

In the previous week, Omada Health had 9 more articles in the media than Sotera Health. MarketBeat recorded 11 mentions for Omada Health and 2 mentions for Sotera Health. Sotera Health's average media sentiment score of 0.83 beat Omada Health's score of 0.75 indicating that Sotera Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Omada Health 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sotera Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, OMDA or VCYT?

Veracyte has higher revenue and earnings than Omada Health. Omada Health is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Omada Health $260.21M 5.38 -$12.78M -$0.27 N/A Veracyte $541.74M 8.61 $66.35M $1.09 53.64

Is OMDA or VCYT more profitable?

Veracyte has a net margin of 16.25% compared to Omada Health's net margin of -2.22%. Veracyte's return on equity of 9.07% beat Omada Health's return on equity. Company Net Margins Return on Equity Return on Assets Omada Health -2.22% -1.82% -1.36% Veracyte 16.25% 9.07% 8.38%

Does the media refer more to OMDA or VCYT?

In the previous week, Veracyte had 3 more articles in the media than Omada Health. MarketBeat recorded 14 mentions for Veracyte and 11 mentions for Omada Health. Veracyte's average media sentiment score of 0.86 beat Omada Health's score of 0.75 indicating that Veracyte is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Omada Health 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Veracyte 5 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer DFTX or OMDA?

In the previous week, Definium Therapeutics and Definium Therapeutics both had 11 articles in the media. Definium Therapeutics' average media sentiment score of 0.89 beat Omada Health's score of 0.75 indicating that Definium Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Definium Therapeutics 3 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Omada Health 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Omada Health (OMDA) Competitors

$23.50 +0.06 (+0.24%)

As of 02:41 PM Eastern

Compare

OMDA vs. CELC, CAI, SHC, VCYT, and DFTX

Should you buy Omada Health stock or one of its competitors? MarketBeat compares Omada Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Omada Health include Celcuity (CELC), Caris Life Sciences (CAI), Sotera Health (SHC), Veracyte (VCYT), and Definium Therapeutics (DFTX). These companies are all part of the "healthcare" industry.

How does Omada Health compare to Celcuity?

Omada Health (NASDAQ:OMDA) and Celcuity (NASDAQ:CELC) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, analyst recommendations, profitability, dividends, institutional ownership and risk.

Omada Health has higher revenue and earnings than Celcuity. Omada Health is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omada Health	$260.21M	5.38	-$12.78M	-$0.27	N/A
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A

63.3% of Celcuity shares are held by institutional investors. 6.4% of Omada Health shares are held by insiders. Comparatively, 13.3% of Celcuity shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Omada Health currently has a consensus price target of $22.91, suggesting a potential downside of 2.64%. Celcuity has a consensus price target of $155.18, suggesting a potential upside of 65.97%. Given Celcuity's stronger consensus rating and higher probable upside, analysts plainly believe Celcuity is more favorable than Omada Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omada Health	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.69
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83

In the previous week, Celcuity had 1 more articles in the media than Omada Health. MarketBeat recorded 12 mentions for Celcuity and 11 mentions for Omada Health. Celcuity's average media sentiment score of 0.82 beat Omada Health's score of 0.75 indicating that Celcuity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omada Health	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Celcuity	5 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Celcuity has a net margin of 0.00% compared to Omada Health's net margin of -2.22%. Omada Health's return on equity of -1.82% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omada Health	-2.22%	-1.82%	-1.36%
Celcuity	N/A	-244.61%	-50.22%

Summary

Celcuity beats Omada Health on 9 of the 14 factors compared between the two stocks.

How does Omada Health compare to Caris Life Sciences?

Omada Health (NASDAQ:OMDA) and Caris Life Sciences (NASDAQ:CAI) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, profitability, dividends, risk and analyst recommendations.

In the previous week, Omada Health and Omada Health both had 11 articles in the media. Caris Life Sciences' average media sentiment score of 0.98 beat Omada Health's score of 0.75 indicating that Caris Life Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omada Health	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Caris Life Sciences	3 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Caris Life Sciences has a net margin of 3.75% compared to Omada Health's net margin of -2.22%. Caris Life Sciences' return on equity of 98.28% beat Omada Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omada Health	-2.22%	-1.82%	-1.36%
Caris Life Sciences	3.75%	98.28%	48.87%

Omada Health has higher earnings, but lower revenue than Caris Life Sciences. Omada Health is trading at a lower price-to-earnings ratio than Caris Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omada Health	$260.21M	5.38	-$12.78M	-$0.27	N/A
Caris Life Sciences	$812.03M	5.96	-$68.09M	-$7.61	N/A

Omada Health currently has a consensus price target of $22.91, indicating a potential downside of 2.64%. Caris Life Sciences has a consensus price target of $26.11, indicating a potential upside of 52.52%. Given Caris Life Sciences' higher possible upside, analysts plainly believe Caris Life Sciences is more favorable than Omada Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omada Health	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.69
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45

Summary

Caris Life Sciences beats Omada Health on 8 of the 12 factors compared between the two stocks.

How does Omada Health compare to Sotera Health?

Omada Health (NASDAQ:OMDA) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability.

In the previous week, Omada Health had 9 more articles in the media than Sotera Health. MarketBeat recorded 11 mentions for Omada Health and 2 mentions for Sotera Health. Sotera Health's average media sentiment score of 0.83 beat Omada Health's score of 0.75 indicating that Sotera Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omada Health	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sotera Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

91.0% of Sotera Health shares are held by institutional investors. 6.4% of Omada Health shares are held by insiders. Comparatively, 15.4% of Sotera Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Sotera Health has higher revenue and earnings than Omada Health. Omada Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omada Health	$260.21M	5.38	-$12.78M	-$0.27	N/A
Sotera Health	$1.16B	4.43	$77.94M	$0.41	44.11

Sotera Health has a net margin of 9.91% compared to Omada Health's net margin of -2.22%. Sotera Health's return on equity of 39.73% beat Omada Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omada Health	-2.22%	-1.82%	-1.36%
Sotera Health	9.91%	39.73%	7.05%

Omada Health presently has a consensus price target of $22.91, indicating a potential downside of 2.64%. Sotera Health has a consensus price target of $20.25, indicating a potential upside of 11.97%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts clearly believe Sotera Health is more favorable than Omada Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omada Health	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.69
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Summary

Sotera Health beats Omada Health on 12 of the 15 factors compared between the two stocks.

How does Omada Health compare to Veracyte?

Omada Health (NASDAQ:OMDA) and Veracyte (NASDAQ:VCYT) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends.

Veracyte has higher revenue and earnings than Omada Health. Omada Health is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omada Health	$260.21M	5.38	-$12.78M	-$0.27	N/A
Veracyte	$541.74M	8.61	$66.35M	$1.09	53.64

In the previous week, Veracyte had 3 more articles in the media than Omada Health. MarketBeat recorded 14 mentions for Veracyte and 11 mentions for Omada Health. Veracyte's average media sentiment score of 0.86 beat Omada Health's score of 0.75 indicating that Veracyte is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omada Health	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Veracyte	5 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Veracyte has a net margin of 16.25% compared to Omada Health's net margin of -2.22%. Veracyte's return on equity of 9.07% beat Omada Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omada Health	-2.22%	-1.82%	-1.36%
Veracyte	16.25%	9.07%	8.38%

Omada Health currently has a consensus price target of $22.91, suggesting a potential downside of 2.64%. Veracyte has a consensus price target of $55.88, suggesting a potential downside of 4.43%. Given Omada Health's stronger consensus rating and higher possible upside, research analysts clearly believe Omada Health is more favorable than Veracyte.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omada Health	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.69
Veracyte	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.60

Summary

Veracyte beats Omada Health on 11 of the 14 factors compared between the two stocks.

How does Omada Health compare to Definium Therapeutics?

Definium Therapeutics (NASDAQ:DFTX) and Omada Health (NASDAQ:OMDA) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

27.9% of Definium Therapeutics shares are held by institutional investors. 2.4% of Definium Therapeutics shares are held by insiders. Comparatively, 6.4% of Omada Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Definium Therapeutics presently has a consensus price target of $49.23, indicating a potential upside of 6.63%. Omada Health has a consensus price target of $22.91, indicating a potential downside of 2.64%. Given Definium Therapeutics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Definium Therapeutics is more favorable than Omada Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Definium Therapeutics	1 Sell rating(s)	0 Hold rating(s)	14 Buy rating(s)	2 Strong Buy rating(s)	3.00
Omada Health	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.69

Omada Health has higher revenue and earnings than Definium Therapeutics. Omada Health is trading at a lower price-to-earnings ratio than Definium Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Definium Therapeutics	N/A	N/A	-$183.79M	-$2.49	N/A
Omada Health	$260.21M	5.38	-$12.78M	-$0.27	N/A

Definium Therapeutics has a net margin of 0.00% compared to Omada Health's net margin of -2.22%. Omada Health's return on equity of -1.82% beat Definium Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Definium Therapeutics	N/A	-100.30%	-69.22%
Omada Health	-2.22%	-1.82%	-1.36%

In the previous week, Definium Therapeutics and Definium Therapeutics both had 11 articles in the media. Definium Therapeutics' average media sentiment score of 0.89 beat Omada Health's score of 0.75 indicating that Definium Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Definium Therapeutics	3 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Omada Health	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Definium Therapeutics beats Omada Health on 8 of the 14 factors compared between the two stocks.

Get Omada Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OMDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OMDA vs. The Competition

Export

Metric	Omada Health	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.40B	$9.46B	$6.78B	$12.65B
Dividend Yield	N/A	1.62%	2.68%	8.43%
P/E Ratio	-86.93	25.42	27.13	24.40
Price / Sales	5.38	19.40	525.28	91.46
Price / Cash	N/A	112.66	48.59	59.39
Price / Book	5.93	6.12	10.85	6.33
Net Income	-$12.78M	$177.20M	$3.59B	$331.45M
7 Day Performance	2.40%	0.64%	-1.34%	0.18%
1 Month Performance	35.78%	7.67%	2.96%	-0.72%
1 Year Performance	30.80%	14.61%	28.93%	20.53%

Omada Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OMDA Omada Health	1.7 of 5 stars	$23.49 +0.2%	$22.91 -2.5%	+33.6%	$1.40B	$260.21M	N/A	849	Analyst Downgrade Gap Up
CELC Celcuity	3.7092 of 5 stars	$108.58 +0.6%	$152.09 +40.1%	+707.6%	$5.26B	N/A	N/A	40	News Coverage Analyst Forecast Gap Down
CAI Caris Life Sciences	4.3152 of 5 stars	$17.81 -2.7%	$26.11 +46.6%	N/A	$5.17B	$812.03M	N/A	1,846	News Coverage Insider Trade
SHC Sotera Health	2.7478 of 5 stars	$17.86 -0.4%	$20.25 +13.4%	+53.1%	$5.11B	$1.16B	22.70	3,000
VCYT Veracyte	2.7497 of 5 stars	$57.99 +1.6%	$50.43 -13.0%	+112.5%	$4.55B	$517.15M	53.20	790	Positive News Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OMDA) was last updated on 7/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Omada Health (OMDA) Competitors

OMDA vs. CELC, CAI, SHC, VCYT, and DFTX

How does Omada Health compare to Celcuity?

Summary

How does Omada Health compare to Caris Life Sciences?

Summary

How does Omada Health compare to Sotera Health?

Summary

How does Omada Health compare to Veracyte?

Summary

How does Omada Health compare to Definium Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OMDA vs. The Competition

Omada Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Omada Health (OMDA) Competitors

OMDA vs. CELC, CAI, SHC, VCYT, and DFTX

How does Omada Health compare to Celcuity?

Which has better valuation and earnings, OMDA or CELC?

Do insiders and institutionals hold more shares of OMDA or CELC?

Do analysts recommend OMDA or CELC?

Does the media refer more to OMDA or CELC?

Is OMDA or CELC more profitable?

Summary

How does Omada Health compare to Caris Life Sciences?

Does the media prefer OMDA or CAI?

Is OMDA or CAI more profitable?

Which has stronger earnings & valuation, OMDA or CAI?

Do analysts prefer OMDA or CAI?

Summary

How does Omada Health compare to Sotera Health?

Does the media prefer OMDA or SHC?

Do institutionals & insiders believe in OMDA or SHC?

Which has stronger earnings and valuation, OMDA or SHC?

Is OMDA or SHC more profitable?

Do analysts recommend OMDA or SHC?

Summary

How does Omada Health compare to Veracyte?

Which has better earnings and valuation, OMDA or VCYT?

Does the media refer more to OMDA or VCYT?

Is OMDA or VCYT more profitable?

Do analysts prefer OMDA or VCYT?

Summary

How does Omada Health compare to Definium Therapeutics?

Do insiders & institutionals hold more shares of DFTX or OMDA?

Do analysts recommend DFTX or OMDA?

Which has better valuation and earnings, DFTX or OMDA?

Is DFTX or OMDA more profitable?

Does the media prefer DFTX or OMDA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OMDA vs. The Competition

Omada Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools